kaloramainformation.com
prenatal | Kalorama Information Home
http://www.kaloramainformation.com/Tags/prenatal
Skip to main content. Early Implications of the Zika Virus for the U.S. Diagnostics Market. In addition to its blog posts regarding infectious disease threats, Kalorama Information offers a comprehensive market research report for global infectious disease testing. Since the last blog entry. Mosquitoes, present in up to 25 U.S. states. Read more about Early Implications of the Zika Virus for the U.S. Diagnostics Market. The Market for Prenatal, Newborn and Carrier Genetic Testing. Read more about Affymet...
kaloramainformation.com
medical device | Kalorama Information Home
http://www.kaloramainformation.com/Tags/medical-device
Skip to main content. FDA Warning Formalizes Growing Cybersecurity Concerns for Medical Devices. Read more about FDA Warning Formalizes Growing Cybersecurity Concerns for Medical Devices. Recently Proposed CMS Rules to Shape Opportunities in Advanced Patient Monitoring and Wearable Devices Markets. This blog covers markets treated fully in the recently released Kalorama Information market research reports. Advanced Remote Patient Monitoring Systems, 8th Edition. The Market for Wearable Devices. Read more...
kaloramainformation.com
long term care | Kalorama Information Home
http://www.kaloramainformation.com/Tags/long-term-care
Skip to main content. Recently Proposed CMS Rules to Shape Opportunities in Advanced Patient Monitoring and Wearable Devices Markets. This blog covers markets treated fully in the recently released Kalorama Information market research reports. Advanced Remote Patient Monitoring Systems, 8th Edition. The Market for Wearable Devices. Read more about Recently Proposed CMS Rules to Shape Opportunities in Advanced Patient Monitoring and Wearable Devices Markets. Log-in to the Knowledge Center. Next-Generation...
kaloramainformation.com
Recently Proposed CMS Rules to Shape Opportunities in Advanced Patient Monitoring and Wearable Devices Markets | Kalorama Information Home
http://www.kaloramainformation.com/article/2015-07/Recently-Proposed-CMS-Rules-Shape-Opportunities-Advanced-Patient-Monitoring-and
Skip to main content. Recently Proposed CMS Rules to Shape Opportunities in Advanced Patient Monitoring and Wearable Devices Markets. Recently Proposed CMS Rules to Shape Opportunities in Advanced Patient Monitoring and Wearable Devices Markets. This blog covers markets treated fully in the recently released Kalorama Information market research reports. Advanced Remote Patient Monitoring Systems, 8th Edition. The Market for Wearable Devices. Related titles to this blog post,. The World Market for Infusio...
kaloramainformation.com
POC | Kalorama Information Home
http://www.kaloramainformation.com/Tags/POC
Skip to main content. Envisioning an Essential Diagnostics List (EDL) and Its IVD Market Impact. Kalorama Information offers relevant market research in the areas of molecular point-of-care (POC) diagnostics. And physician office laboratory (POL) test markets. Market information in this post was drawn from the associated reports. In a recent article of the New England Journal of Medicine. Read more about Envisioning an Essential Diagnostics List (EDL) and Its IVD Market Impact. The market for point of ca...
kaloramainformation.com
professional POC | Kalorama Information Home
http://www.kaloramainformation.com/Tags/professional-POC
Skip to main content. POC IVD a Viable Business Model for Theranos. To provide actionable information at the time it matters most. Additionally remains just as viable if the company chooses to further develop its technology as a POCT analyzer. Alternatively, continued plans for Theranos in clinical lab services must account for the company’s currently low-margin, if not unprofitable, operations using third-party analyzers. Read more about POC IVD a Viable Business Model for Theranos. For additional curre...
kaloramainformation.com
New Developments in Point-of-Care (POC) Diagnostics – Kalorama White Paper | Kalorama Information Home
http://www.kaloramainformation.com/article/2015-07/New-Developments-Point-Care-POC-Diagnostics-–-Kalorama-White-Paper
Skip to main content. New Developments in Point-of-Care (POC) Diagnostics Kalorama White Paper. New Developments in Point-of-Care (POC) Diagnostics Kalorama White Paper. This post was adapted from a recently released Kalorama Information white paper on clinical point-of-care diagnostics. To receive the white paper, contact a customer service representative at 1-800-298-5603 (intl. 1 240 747 3096) or customerservice@kaloramainformation.com. The World Market for Point of Care (POC) Diagnostics. After regis...
kaloramainformation.com
microarrays | Kalorama Information Home
http://www.kaloramainformation.com/Tags/microarrays
Skip to main content. MiRNA Tools Lead Development of Next-Generation Therapeutics and Diagnostics. MicroRNA Tools and Services Market. Tool markets in the report include qRT-PCR, hybridization (arrays) and next-generation sequencing (NGS) as well as miRNA research-specific reagents such as miRNA mimics and inhibitors. Read more about miRNA Tools Lead Development of Next-Generation Therapeutics and Diagnostics. The Market for Prenatal, Newborn and Carrier Genetic Testing. Read more about Affymetrix Acqui...
kaloramainformation.com
AACC 2015: Point-of-Care a Focus at Meeting | Kalorama Information Home
http://www.kaloramainformation.com/article/2015-07/AACC-2015-Point-Care-Focus-Meeting
Skip to main content. AACC 2015: Point-of-Care a Focus at Meeting. AACC 2015: Point-of-Care a Focus at Meeting. Kalorama estimates the world point of care market to be 17 billion as of 2014, according to its recent report detailing the POC market and profiling companies. The report is available on its website Point of Care Diagnostics. ( http:/ www.kaloramainformation.com/Point-Care-POC-9030928/. Among the developments at the meeting so far:. Provided demonstrations of its. Tuesday marked the first day o...
kaloramainformation.com
Vaccine Revenues Near 24 Billion | Kalorama Information Home
http://www.kaloramainformation.com/article/2014-05/Vaccine-Revenues-Near-24-Billion
Skip to main content. Vaccine Revenues Near 24 Billion. Vaccine Revenues Near 24 Billion. In 2013, the world market for preventive vaccines totaled $23.9 billion, up from $22.8 billion in 2012 as sales in all segments expanded, according to our latest report. Among some the growth leaders was influenza vaccines, where greater awareness, new products and overstock recovery lead to 3.1 billion in revenues, up from 2.8 billion in 2012. New Products are part of the reason for the increase, according to Kalor...
